82674-16-6 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1] Russian Journal of General Chemistry, 2016, vol. 86, # 7, p. 1613 - 1618[2] Zh. Obshch. Khim., 2016, vol. 86, # 7, p. 1135 - 1140,6
Reference: [1] Patent: US2009/54482, 2009, A1,
Reference: [1] RSC Advances, 2015, vol. 5, # 129, p. 107012 - 107019
Reference: [1]Albrecht, Markus; Blau, Oliver; Witt, Karen; Wegelius, Elina; Nissinen, Maija; Rissanen, Kari; Froehlich, Roland
[Synthesis, 1999, # 10, p. 1819 - 1829]
Reference: [1]Current Patent Assignee: GUANGDONG UNIVERSITY OF TECHNOLOGY; UNIV DE PARIS VII - CN110041309, 2019, A
Location in patent: Paragraph 0077-0080
Reference: [1]Current Patent Assignee: ONXEO - EP2147912, 2010, A1
Location in patent: Page/Page column 9; 10; 11
[2]Current Patent Assignee: Novartis (w/o Sandoz); NOVARTIS AG - US2875126, 1956, A
* For details of the synthesis route, please refer to the original source to ensure accuracy.